{
    "Trade/Device Name(s)": [
        "MicroScan Dried Gram-Negative MIC/Combo Panels with Ciprofloxacin-S (0.004 - 8 \u00b5g/mL)",
        "Microdilution Minimum Inhibitory Concentration (MIC) Panels"
    ],
    "Submitter Information": "Beckman Coulter Inc.",
    "510(k) Number": "K172912",
    "Predicate Device Reference 510(k) Number(s)": [
        "K162740"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LTT",
        "JWY",
        "LRG",
        "LTW"
    ],
    "Summary Letter Date": "September 22, 2017",
    "Summary Letter Received Date": "September 25, 2017",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Ciprofloxacin"
    ],
    "Specimen Type(s)": [
        "Colonies of rapidly growing aerobic and facultative anaerobic gram-negative bacilli"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "MicroScan instrumentation",
        "autoSCAN-4 instrument",
        "WalkAway system"
    ],
    "Method(s)/Technology(ies)": [
        "Broth dilution susceptibility test",
        "Panel rehydration",
        "Visual reading"
    ],
    "Methodologies": [
        "Minimum inhibitory concentration (MIC) determination"
    ],
    "Submission Type(s)": [
        "Panel",
        "Reagent",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for MicroScan Dried Gram-Negative MIC/Combo Panels with Ciprofloxacin-S for antimicrobial susceptibility testing of gram-negative bacilli.",
    "Indications for Use Summary": "Used to determine quantitative and/or qualitative antimicrobial agent susceptibility of colonies of rapidly growing aerobic and facultative anaerobic gram-negative bacilli, specifically for ciprofloxacin susceptibility testing with Salmonella Typhi.",
    "fda_folder": "Microbiology"
}